Evidence map›Paper›PMID 34858907›Full record

ArticleFrontiers in pediatrics2021

Use of Eculizumab in Pediatric Patients With Transplant Associated Thrombotic Microangiopathy.

Laura Gomez-Ganda, Maria Isabel Benitez-Carabante, Aurora Fernandez-Polo, Marina Muñoz-Lopez, Berta Renedo-Miro, Gema Ariceta, Cristina Diaz De Heredia

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Kidney international reports · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Laura Gomez-GandaPharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Maria Isabel Benitez-CarabantePediatric Oncology and Hematology Service, Hematopoietic Stem Cell Transplantation Section, Vall d'Hebron University Hospital, Barcelona, Spain.
Aurora Fernandez-PoloPharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Marina Muñoz-LopezPediatric Nephrology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Berta Renedo-MiroPharmacy Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Gema AricetaPediatric Nephrology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Cristina Diaz De HerediaPediatric Oncology and Hematology Service, Hematopoietic Stem Cell Transplantation Section, Vall d'Hebron University Hospital, Barcelona, Spain.
Vall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CH50complement inhibitorcomplement systemeculizumabhematopoietic stem cell transplant (HSCT)hrTA-TMAsC5b-9 (serum complement membrane attack complex)thrombotic microangiopathy (TA-TMA)

Identifiers

PMID34858907
PMCPMC8632356
OpenAlexW3213074348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.